world-gastroenterology-2018-keynote

3 / 5

Volume 4 Journal of Hepatology & Gastrointestinal Disorder World Gastroenterology 2018
September 03-04, 2018
Page 20
conferenceseries.com
September 03-04, 2018 Dubai, UAE
Gastroenterology and Hepatology
17th International Conference on
Eosinophilic esophagitis
It’s believed that the prevalence of atopic disorders is increasing worldwide. Gastrointestinal allergic disorders are no
stranger to this phenomenon. Over the last two decades a new disease was described called eosinophilic esophagitis which
simply means an allergic inflammatory reaction in the esophagus. This could be related to ingested or possibly inhaled
allergens. Typically these young children present with difficulty in swallowing and dysphagia and frequently with food
impaction with regular food. They have functional obstruction rather than at anatomical obstruction. During endoscopy
an abnormal esophageal mucosa can be noted sometimes with some white spots indicated some eosinophilic abscesses,
linear furrows and during formation of the esophagus. Biopsy should be taken to confirm the diagnosis which normally
shows increased number of eosinophils. A cutoff point is described to be more than 15 eosinophils per high-power field.
Typically these patients they don’t have eosinophilic infiltrates in other parts of the gastrointestinal system. The mainstay of
treatment is elemental diet avoiding the commonest food allergies that includes milk, eggs, wheat, soy, nuts and seafood. In
the Middle East allergy to sesame seems to be another common allergen. Also these patients that will require “swallowed
topical steroid” in addition to a proton pump inhibitor. Unfortunately this is a chronic disorder and these patients need to be
in diet for a long period of time with the above medications. Dilatation if required can be associated with higher increased
risk of perforation.
Biography
Mohamad Miqdady is American Board certified in Pediatric Gastroenterology, Hepatology and Nutrition. He is the Division Chief, Ped. GI, Hepatology and Nutrition
Division at Sheikh Khalifa Medical City in UAE. He is also an Adjunct Staff at Cleveland Clinic, USA. He is also the member of the FISPGHAN Council (Federation
of International Societies of Pediatric Gastruenterology Hepatology and Nutrition) expert member FISPGHAN Malnutrition/Obesity expert team. He has completed
his Fellowship in Pediatric Gastroenterology at Baylor College of Medicine and Texas Children’s Hospital in Houston, TX, USA. He held the position of Assistant
Professor at Jordan University of Science and Technology in Jordan for six years prior joining SKMC. His main research interests include feeding difficulties, picky
eating, obesity, procedural sedation, allergic GI disorders and celiac disease.
Mohamad Miqdady1, 2
1Sheikh Khalifa Medical City, UAE
2Cleveland Clinic, USA
Mohamad Miqdady, J Hepatol Gastroint Dis 2018, Volume 4
DOI: 10.4172/2475-3181-C1-001
Notes: